DK355489D0 - Anvendelse af substituerede 3,4-dihydro-2h-benzopyraner til fremstilling af et laegemiddel imod obstruktive funktionsforstyrrelser af lungerne og/eller forstyrrelser af urinafgangsvejene - Google Patents

Anvendelse af substituerede 3,4-dihydro-2h-benzopyraner til fremstilling af et laegemiddel imod obstruktive funktionsforstyrrelser af lungerne og/eller forstyrrelser af urinafgangsvejene

Info

Publication number: DK355489D0
Authority: DK; Denmark
Prior art keywords: disorders; alkyl; dihydro; substituted; urinary
Prior art date: 1988-07-19

Application number

DK355489A

Other languages

English (en)

Other versions

DK171782B1 (da

DK355489A (da

Inventor

Heinrich Christian Englert

Erik Klaus

Dieter Mania

Bernward Schoelkens

Original Assignee

Hoechst Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-07-19

Filing date

1989-07-18

Publication date

1989-07-18

1989-07-18 Application filed by Hoechst Ag filed Critical Hoechst Ag

1989-07-18 Publication of DK355489D0 publication Critical patent/DK355489D0/da

1990-01-20 Publication of DK355489A publication Critical patent/DK355489A/da

1997-05-26 Application granted granted Critical

1997-05-26 Publication of DK171782B1 publication Critical patent/DK171782B1/da

Links

210000004072 lung Anatomy 0.000 title 1
230000000414 obstructive effect Effects 0.000 title 1
230000002485 urinary effect Effects 0.000 title 1
125000006526 (C1-C2) alkyl group Chemical group 0.000 abstract 2
125000006536 (C1-C2)alkoxy group Chemical group 0.000 abstract 2
125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
208000026723 Urinary tract disease Diseases 0.000 abstract 1
125000000217 alkyl group Chemical group 0.000 abstract 1
125000003118 aryl group Chemical group 0.000 abstract 1
125000004432 carbon atom Chemical group C* 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
229910052736 halogen Inorganic materials 0.000 abstract 1
150000002367 halogens Chemical class 0.000 abstract 1
125000001072 heteroaryl group Chemical group 0.000 abstract 1
125000005842 heteroatom Chemical group 0.000 abstract 1
150000004880 oxines Chemical class 0.000 abstract 1
125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
208000014001 urinary system disease Diseases 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pulmonology (AREA)
Reproductive Health (AREA)
Urology & Nephrology (AREA)
Endocrinology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Pyrane Compounds (AREA)

DK355489A 1988-07-19 1989-07-18 Anvendelse af 3,4-dihydro-2H-benzo[b]pyraner til fremstilling af et lægemiddel imod obstruktive funktionsforstyrrelser af lungerne DK171782B1 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE3824446A DE3824446A1 (de)	1988-07-19	1988-07-19	Verwendung substituierter 3,4-dihydro-2h-benzopyrane als heilmittel gegen obstruktive funktionsstoerungen der lunge und/oder stoerungen der ableitenden harnwege
DE3824446		1988-07-19

Publications (3)

Publication Number	Publication Date
DK355489D0 true DK355489D0 (da)	1989-07-18
DK355489A DK355489A (da)	1990-01-20
DK171782B1 DK171782B1 (da)	1997-05-26

Family

ID=6359009

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK355489A DK171782B1 (da)	1988-07-19	1989-07-18	Anvendelse af 3,4-dihydro-2H-benzo[b]pyraner til fremstilling af et lægemiddel imod obstruktive funktionsforstyrrelser af lungerne

Country Status (18)

Country	Link
EP (2)	EP0351720B1 (da)
JP (1)	JPH0273015A (da)
KR (1)	KR900001367A (da)
AT (1)	ATE110270T1 (da)
AU (1)	AU621388B2 (da)
CA (1)	CA1336891C (da)
CZ (1)	CZ417091A3 (da)
DE (2)	DE3824446A1 (da)
DK (1)	DK171782B1 (da)
ES (1)	ES2061816T3 (da)
FI (1)	FI893460A7 (da)
HU (1)	HU210149B (da)
IE (1)	IE63872B1 (da)
IL (1)	IL91015A (da)
NZ (1)	NZ229961A (da)
PH (1)	PH26696A (da)
PT (1)	PT91197B (da)
ZA (1)	ZA895459B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW244350B (da) *	1991-12-14	1995-04-01	Hoechst Ag
TW316850B (da) *	1992-02-28	1997-10-01	Takeda Pharm Industry Co Ltd
HUT72741A (en) *	1992-12-19	1996-05-28	Alkaloida Vegyeszeti Gyar	Method for producing benzopyrane derivatives and pharmaceutical compositions containing them
GB9316111D0 (en) *	1993-08-04	1993-09-22	Pfizer Ltd	Benzopyrans
AU2273301A (en)	1999-12-23	2001-07-09	Robert E. Coifman	Methods and formulations for the efficient delivery of water-insoluble drugs by nebulizer
KR100475147B1 (ko) *	2002-09-09	2005-03-10	정의상	알루미나 분진 중의 유해가스 제거를 위한 탈취제 조성물
ATE407724T1 (de)	2002-11-12	2008-09-15	Warner Lambert Co	Methode zur stimulierung von haarwuchs auf der basis von benzopyranen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3364734D1 (en) *	1982-10-19	1986-08-28	Beecham Group Plc	Novel chromans and chromenes
GB8419515D0 (en) *	1984-07-31	1984-09-05	Beecham Group Plc	Treatment
GB8513369D0 (en) *	1985-05-28	1985-07-03	Beecham Group Plc	Treatment
DE3703227A1 (de) *	1987-02-04	1988-08-18	Hoechst Ag	Substituierte 3,4-dihydro-2h-benzopyrane, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen
ES2058148T3 (es) *	1987-02-04	1994-11-01	Hoechst Ag	N-benzopiranil-lactamas sustituidas con alquilo, procedimiento para su preparacion, su empleo, asi como preparados farmaceuticos a base de estos compuestos.

1988
- 1988-07-19 DE DE3824446A patent/DE3824446A1/de not_active Withdrawn
1989
- 1989-07-14 EP EP89112897A patent/EP0351720B1/de not_active Expired - Lifetime
- 1989-07-14 AT AT89112897T patent/ATE110270T1/de not_active IP Right Cessation
- 1989-07-14 DE DE58908228T patent/DE58908228D1/de not_active Expired - Fee Related
- 1989-07-14 ES ES89112897T patent/ES2061816T3/es not_active Expired - Lifetime
- 1989-07-17 FI FI893460A patent/FI893460A7/fi not_active IP Right Cessation
- 1989-07-17 HU HU893591A patent/HU210149B/hu not_active IP Right Cessation
- 1989-07-17 EP EP93105146A patent/EP0560399A1/de not_active Withdrawn
- 1989-07-17 PH PH38951A patent/PH26696A/en unknown
- 1989-07-17 NZ NZ229961A patent/NZ229961A/xx unknown
- 1989-07-18 ZA ZA895459A patent/ZA895459B/xx unknown
- 1989-07-18 IE IE232389A patent/IE63872B1/en not_active IP Right Cessation
- 1989-07-18 KR KR1019890010129A patent/KR900001367A/ko not_active Ceased
- 1989-07-18 AU AU38189/89A patent/AU621388B2/en not_active Ceased
- 1989-07-18 IL IL9101589A patent/IL91015A/en not_active IP Right Cessation
- 1989-07-18 PT PT91197A patent/PT91197B/pt not_active IP Right Cessation
- 1989-07-18 DK DK355489A patent/DK171782B1/da not_active IP Right Cessation
- 1989-07-18 JP JP1183848A patent/JPH0273015A/ja active Pending
- 1989-07-18 CA CA000605990A patent/CA1336891C/en not_active Expired - Fee Related
1991
- 1991-12-30 CZ CS914170A patent/CZ417091A3/cs unknown

Also Published As

Publication number	Publication date
NZ229961A (en)	1991-11-26
EP0351720A2 (de)	1990-01-24
AU3818989A (en)	1990-01-25
EP0560399A1 (de)	1993-09-15
FI893460A0 (fi)	1989-07-17
ATE110270T1 (de)	1994-09-15
EP0351720A3 (de)	1992-01-02
JPH0273015A (ja)	1990-03-13
CZ417091A3 (en)	1993-02-17
IE63872B1 (en)	1995-06-14
KR900001367A (ko)	1990-02-27
IL91015A (en)	1994-11-28
FI893460A7 (fi)	1990-01-20
DK171782B1 (da)	1997-05-26
DE3824446A1 (de)	1990-01-25
AU621388B2 (en)	1992-03-12
EP0351720B1 (de)	1994-08-24
CA1336891C (en)	1995-09-05
ZA895459B (en)	1990-03-28
PT91197B (pt)	1995-07-18
ES2061816T3 (es)	1994-12-16
PT91197A (pt)	1990-02-08
DK355489A (da)	1990-01-20
HU210149B (en)	1995-02-28
DE58908228D1 (de)	1994-09-29
HUT55988A (en)	1991-07-29
IE892323L (en)	1990-01-19
PH26696A (en)	1992-09-15

Legal Events

Date	Code	Title	Description
2003-03-03	PBP	Patent lapsed	Country of ref document: DK

Publication	Publication Date	Title
FI940414A0 (fi)	1994-01-27	Kinoliini- tai kinatsoliinijohdannaiset, niiden valmistus ja käyttö
DK355489A (da)	1990-01-20	Anvendelse af substituerede 3,4-dihydro-2h-benzopyraner til fremstilling af et laegemiddel imod obstruktive funktionsforstyrrelser af lungerne og/eller forstyrrelser af urinafgangsvejene
ES2061518T3 (es)	1994-12-16	Compuestos que tienen propiedades antitumorales y antibacterianas.
DE59403757D1 (de)	1997-09-25	Neue Chinolon- und Naphthyridoncarbonsäurederivate
IE880294L (en)	1988-08-04	Substituted 3,4-dihydro-2h-benzopyrans, process for their¹preparation, their use and pharmaceutical products based on¹these compounds
DE68919378D1 (de)	1994-12-22	Thienotriazolodiazepine und ihre pharmazeutische Verwendung.
IE880295L (en)	1988-08-04	Alkyl-substitued n-benzopyranyllactams
ATE207479T1 (de)	2001-11-15	Kristalle von derivaten von chinozon carbonsäure- hydraten
DK0528164T3 (da)	1996-09-30	Anvendelse af xanthinderivater til fremstilling af et lægemiddel til behandling af sekundære nervecelleskader og funktionsforstyrrelser efter kranie-hjerne-traumer
AU560141B2 (en)	1987-04-02	Piperazine derivatives of theophylline
ES523425A0 (es)	1984-11-01	Un metodo para preparar nuevos derivados de guanina
DE58905079D1 (de)	1993-09-09	Neue alpha-aminocarbonsaeure-derivate, ihre herstellung und verwendung.
ES514553A0 (es)	1983-11-01	"un procedimiento para la preparacion de derivados piperacinicos de la teobromina".
TR26593A (tr)	1995-03-15	HIDROFIL DURUM GETIRILMIS TRIGLISERID'LERIN üRETILMESINE MAHSUS USUL.
ES2112867T3 (es)	1998-04-16	Sales de acidos acil-(2'-hidroxibifenil-2-il)-fosfinicos, su produccion y su utilizacion.
DK42481A (da)	1981-08-01	Fremgangsmaade til fremstilling af piperazinderivater af theophyllin
ATE138914T1 (de)	1996-06-15	Indeno-d-pyrimidonverbindungen zur verwendung in der medizin
ES2187653T3 (es)	2003-06-16	Esteres del acido azoliloxibencil-alcoxiacrilico, procedimiento para su obtencion y su empleo.
ES2096800T3 (es)	1997-03-16	Benzo(b)tiofen-3-il-piperazinas, un procedimiento para su preparacion y su uso como medicamentos.
DK0631777T3 (da)	2001-03-05	Anvendelse af beta-naphtoquinonderivater til hæmning af blodpladesammenklumpning
SE8901570D0 (sv)	1989-05-02	Organic salts of cysteine derivatives
ES2076054T3 (es)	1995-10-16	Nuevas amino-alquil-cromonas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
NO900646D0 (no)	1990-02-09	Fremgangsmaate for fremstilling av calsiumantagonister.
PT88234A (pt)	1989-06-30	Processo para a preparacao de derivados de cloroanilina
ATE57185T1 (de)	1990-10-15	Pyrido(1,2-a>pyrimidinderivate.